AW
SLS icon

Avion Wealth’s SELLAS Life Sciences SLS Stock Holding History

Avion Wealth’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2K Sell
166
-407
-71% -$2.81K ﹤0.01% 1123
2026
Q1 		$2K Hold
573
– – ﹤0.01% 912
2025
Q4 		$2K Hold
573
– – ﹤0.01% 920
2025
Q3 		$0 Hold
573
– – ﹤0.01% 1524
2025
Q2 		$1K Hold
573
– – ﹤0.01% 1066
2025
Q1 		$0 Buy
+573
New +$680 ﹤0.01% 1337

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Avion Wealth's SLS Position: Q2 2026 in Review

Avion Wealth reduced its SELLAS Life Sciences (SLS) stake by 71% in Q2 2026, selling an estimated $2.81K and leaving 166 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1123.

Avion Wealth first reported a position in SLS in Q1 2025 and has held it in 6 quarters since. 192 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Avion Wealth held 166 shares of SELLAS Life Sciences worth $2K as of Q2 2026.
  • Avion Wealth sold 407 SELLAS Life Sciences shares in Q2 2026, an estimated $2.81K.
  • SELLAS Life Sciences made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #1123 holding.
  • Avion Wealth first reported a position in SELLAS Life Sciences in Q1 2025 and has held it in 6 quarters since.
  • 192 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.